← FDA Drug Approvals (Drugs@FDA)

LEXETTE

NDA · New Drug Application · Sponsor: MAYNE PHARMA · Approved 2018-05-24

Drug application

FDA Application #

NDA210566

Application type

New Drug Application

Brand name

LEXETTE

Generic name

Halobetasol Propionate

Active ingredients

HALOBETASOL PROPIONATE

Dosage form

AEROSOL, FOAM

Route

TOPICAL

Marketing status

Discontinued

Sponsor

MAYNE PHARMA

First approval

2018-05-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown